跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ASTRODAL CAPSULES 20MG - HSA Drug Approval Details
Approvals
/
HSA
/
ASTRODAL CAPSULES 20MG
Approved
THERAPEUTIC
ASTRODAL CAPSULES 20MG
Lotus Pharmaceutical Co., Ltd. Nantou Plant
🇸🇬 Health Sciences Authority
Approval Date
Aug 16, 2016
Approval ID
1f20e4a8295bd400
Company
Lotus Pharmaceutical Co., Ltd. Nantou Plant
Type
Therapeutic
Approval Details
Approval Id
1f20e4a8295bd400
Drug Name
ASTRODAL CAPSULES 20MG
Product Name
ASTRODAL CAPSULES 20MG
Approval Number
SIN15067P
Approval Date
2016-08-16
Registrant
LOTUS INTERNATIONAL PTE. LTD.
Licence Holder
LOTUS INTERNATIONAL PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
L01AX03
Atc Item Name
temozolomide
Pharma Manufacturer Name
LOTUS INTERNATIONAL PTE. LTD.
Company Detail Path
/organization/lotus-international-pte-ltd
Active Ingredients
Temozolomide
20.0mg
TEMOZOLOMIDE
20 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 16, 2016
Approval ID
1f20e4a8295bd400
Type
Therapeutic
Back to HSA Approvals